Oral administration of a dual ETA/ETB receptor antagonist promotes neuroprotection in a rodent model of glaucoma
Nolan R. McGrady, Dorota L. Stankowska, Hayden B. Jefferies, Raghu R. Krishnamoorthy
This study shows that oral macitentan reduces retinal ganglion cell loss and preserves function in a glaucoma model, independent of intraocular pressure reduction.
bioRxiv · Oct 27, 2020 · PreprintNeuroscience